Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
News of the day
Cellerix grants Axcan rights to Cx401 in North America
Madrid, 26th September 2007.- Cellerix, a biopharmaceutical company leader in the clinical development and production of medicines based on adult stem cells, has entered into an exclusive license and development agreement with Axcan Pharma Inc. ("Axcan") for the North American (United States, Canada and Mexico) rights to Cx401. Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. It is listed on the NASDAQ Global Market and on the Toronto Stock... moreWest Announces First Quarter 2008 Results
LIONVILLE, Pa., May 1 2008-- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the first quarter of 2008. Reported results included net after-tax benefits of $1.3 million, or $0.04 per diluted share, representing the combined effects of restructuring charges, a contract settlement gain and a discrete foreign tax benefit. moreSigma-Aldrich to Provide Full Functional Validation Data for Its MISSION(R) shRNA Collection
ST. LOUIS, May 7, 2008-- Sigma-Aldrich(TM) (Nasdaq: SIAL) and the second phase of The RNAi Consortium (TRC2) have commenced functional validation of the Consortium's collection of approximately 160,000 previously-cloned lentiviral-based shRNA vector constructs. Currently, more than 5,000 clones have been tested in the functional validation process. Validated clones covering more than 700 genes are available in Sigma-Aldrich's MISSION(R) shRNA collection, a number expected to grow by 75,000... moreIndustry news search
Most Viewed News
- Eurand In-licenses Corticosteroid GI Product From Chiesi Farmaceutici SpA
- POSITIVE RESULTS FROM PHASE I CLINICAL TRIAL OF SMT D002 FOR THE TREATMENT OF SEBORRHOEA, A PRIMARY CAUSE OF ACNE
- Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer
- UMN Pharma Announces Initiation of Phase I/II trials for Pandemic Influenza Vaccine
- GENOVIS: THE NEW SHARE ISSUE WAS OVERSUBSCRIBED
- RSS Feed...
Latest news by category
Regulatory
- Marketing Authorization granted by European Commission for Adenuric® (TMX-67, febuxostat) for the treatment of hyperuricaemia in gout
- St. Jude Medical Announces FDA Clearance and CE Mark Approval of Strada Carotid Guiding Sheath
- OncoVista Innovative Therapies, Inc. Announces Submission of Request for Pre-IDE Determination Meeting with FDA for AdnaGen's AdnaTest Breast Cancer Device for Detection of Circulating Breast Tumor Cells
- More news...
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us